ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Negotiating with Commercial Payers Takes Planning, Strategy

Vanessa Caceres  |  November 17, 2025

At the inaugural Practice Innovation Summit, two experts offered advice on negotiating insurance contracts.

Filed under:ACR ConvergenceBilling/CodingInsuranceMeeting ReportsPractice Support Tagged with:ACR Convergence 2025BillingHealth Insurancehealth insurance paymentsinsuranceMedicaid funding reductionsMedicarePractice Management

Complicated Cases Discussed in Pediatric Thieves Market

Thomas R. Collins  |  November 14, 2025

At this ACR Convergence 2025 session, clinicians discussed complex and difficult-to-diagnose pediatric cases.

Filed under:ACR ConvergenceMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025case reportpatient carepediatric conditions

ACR Releases New Guideline for Management of SLE at ACR 2025

Mithu Maheswaranathan, MD  |  November 14, 2025

Updating the last iteration in 1999, the new ACR Guideline for Management of SLE was unveiled at ACR Convergence 2025, providing rheumatologists an organ-based approach for therapeutic options for specific lupus manifestations.

Filed under:ACR ConvergenceClinical Criteria/GuidelinesConditionsGuidanceMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2025BiologicsClinical Practice GuidelinesLupussystemic lupus erythematosus (SLE)

Secrets & Pearls of Rheumatology at ACR Convergence 2025

Mithu Maheswaranathan, MD  |  November 12, 2025

Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.

Filed under:ACR ConvergenceMeeting ReportsMyositisOther Rheumatic ConditionsSjögren’s DiseaseSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNconnective tissue diseaseLupusLupus nephritismyositisRaynaud’s phenomenonRheumatic DiseaseSjögren's Diseasesystemic lupus erythematosus (SLE)

Why Target B Cells in SSc-ILD?

Katie Robinson  |  November 11, 2025

In a recent Arthritis & Rheumatology review article, three experts discuss the use of immunosuppressants to target B cells in a patient with systemic sclerosis-interstitial lung disease.

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumSystemic Sclerosis Tagged with:B cellsCAR-T cell therapycase reportimmunosuppressioninterstitial lung disease (ILD)mycophenolate mofetilrituximabSSc-ILDSystemic sclerosis

As Understanding of Long COVID Deepens, the Search for Therapies Continues

Thomas R. Collins  |  November 7, 2025

Experts discussed causes of long COVID & potential therapies at this ACR Convergence 2025 session.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2025COVID-19long COVID

No Longer as Vexing: The Role of Somatic Mutations in Rheumatic Diseases

Jason Liebowitz, MD, FACR  |  November 7, 2025

At this ACR Convergence 2025 session, two experts discussed VEXAS & the role that genetic sequencing should play in the practice of a rheumatologist.

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2025genetic sequencingVEXASVEXAS syndrome

Using Vaccines & Data to Protect the Immunocompromised

Mary Beth Nierengarten  |  November 5, 2025

At this ACR Convergence 2025 session, experts discussed the importance of vaccinating immunocompromised patients with non-live vaccines.

Filed under:ACR ConvergenceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAimmunocompromisedvaccines

JIA: The Transition to Adult Care

Ruth Jessen Hickman, MD  |  November 5, 2025

Experts addressed considerations for how to aid patients with juvenile idiopathic arthritis (JIA) in their transition to adult care, specifically highlighting clinical pearls for those with pediatric uveitis and TMJ arthritis.

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025JIAJIA-associated uveitisjuvenile idiopathic arthritis (JIA)pediatric arthritistemporomandibular joint (TMJ)

The Intersection of Immunology & Rheumatology

Mary Beth Nierengarten  |  November 5, 2025

The winning case study in this year’s Thieves Market highlight a case study from Malaysia with a patient who initially presented with seronegative inflammatory arthritis but experienced recurrent infections and had a porcelain aorta.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2025Bruton’s diseaseX-linked Agammaglobulinemia

  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 331
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences